There is surprisingly little information on the antimicrobial activity of anti-neoplastic agents and no systematic study of this topic seems to have been undertaken. One of the problems involved is that many agents are available only in very small amounts. I report here results of a preliminary study designed to give guidelines for further investigations.
Twenty-one anti-neoplastic agents were screened against a total of 28 microbial strains, chosen to be representative of 4 major groups of pathogenic organisms, namely Gram-positive aerobic bacteria, Gram-negative aerobic bacteria, anaerobic bacteria and yeasts. Anti-neoplastic agents were incorporated into plates of Isosensitest agar (10% lysed horse blood was added when anaerobes were tested), and each plate was inoculated with up to 21 strains using a multi-point inoculator (Denley) giving an inoculum size of 105 bacteria. Incubation was at 370 for 24h aerobically or 48h anaerobically (using the GasPak system). The strains tested had all (except for the Oxford Staphylococcus) recently been isolated from clinical material. The "Gram-positive" group comprised 3 Staphylococcus aureus, 3 Staphylococcus epidermidis and 3 Streptococcus faecalis; the "Gram-negative" group consisted of 3 Escherichia coli, 3 Klebsiella pneumoniae and 3 Pseudomonas aeruginosa; "yeasts" were 3 Candida albicans; "anaerobes" were 5 Clostridium difflcile, 2 Bacteroides fragilis, 1 Veillonella sp. and 1 Clostridium perfringens.
Results are shown in Table I The results show that the antimicrobial activity of anti-neoplastic agents is generally of a low order, but not confined to any one type of agent. The findings confirm and extend the fragmentary reports in the literature concerning mitomycin C, doxyrubicin, 5-fluorouracil, cytarabine and methotrexate (Grey & Hamilton-Miller 1977 , Moody et al., 1978 , Michel et al., 1979 , Jacobs et al., 1979 , Wright & Matsen 1980 ) against a limited range of bacteria, and 5-fluorouracil, hydroxyurea, doxyrubicin, vinblastine, cyclophosphamide and cytarabine against C. albicans (Land et al., 1980) .
Following these results, studies on the antimicrobial action of anti-neoplastic agents might be more profitably confined to possible synergistic effects with antibiotics (Moody et al., 1978) 
